Jason Alger is Chief Financial Officer of Health Catalyst, Inc.. Currently has a direct ownership of 114,106 shares of HCAT, which is worth approximately $886,603. The most recent transaction as insider was on Sep 06, 2024, when has been sold 2,899 shares (Common Stock) at a price of $7.39 per share, resulting in proceeds of $21,423. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 114K
3.44% 3M change
100.39% 12M change
Total Value Held $886,603

Jason Alger Transaction History

Date Transaction Value Shares Traded Shares Held Form
Sep 06 2024
SELL
Open market or private sale
$21,423 $7.39 p/Share
2,899 Reduced 2.48%
114,106 Common Stock
Sep 03 2024
SELL
Payment of exercise price or tax liability
$8,469 $7.27 p/Share
1,165 Reduced 0.99%
117,005 Common Stock
Jun 12 2024
SELL
Open market or private sale
$19,281 $6.83 p/Share
2,823 Reduced 2.33%
118,170 Common Stock
Jun 03 2024
SELL
Payment of exercise price or tax liability
$8,084 $6.53 p/Share
1,238 Reduced 1.01%
120,993 Common Stock
Mar 01 2024
SELL
Payment of exercise price or tax liability
$19,915 $8.05 p/Share
2,474 Reduced 4.52%
52,231 Common Stock
Mar 01 2024
BUY
Grant, award, or other acquisition
-
70,000 Added 36.41%
122,231 Common Stock
Feb 20 2024
BUY
Grant, award, or other acquisition
-
2,778 Added 4.83%
54,705 Common Stock
Dec 06 2023
SELL
Open market or private sale
$16,436 $7.55 p/Share
2,177 Reduced 4.02%
51,927 Common Stock
Dec 01 2023
SELL
Payment of exercise price or tax liability
$21,143 $7.45 p/Share
2,838 Reduced 4.98%
54,104 Common Stock
Sep 06 2023
SELL
Open market or private sale
$25,595 $11.65 p/Share
2,197 Reduced 3.71%
56,942 Common Stock
Sep 01 2023
SELL
Payment of exercise price or tax liability
$10,943 $11.78 p/Share
929 Reduced 1.55%
59,139 Common Stock
Jun 06 2023
SELL
Open market or private sale
$28,060 $11.84 p/Share
2,370 Reduced 3.8%
60,068 Common Stock
Jun 01 2023
SELL
Payment of exercise price or tax liability
$11,981 $11.24 p/Share
1,066 Reduced 1.68%
62,438 Common Stock
Mar 03 2023
SELL
Open market or private sale
$42,220 $14.23 p/Share
2,967 Reduced 5.09%
55,323 Common Stock
Mar 01 2023
SELL
Payment of exercise price or tax liability
$23,064 $14.29 p/Share
1,614 Reduced 2.75%
57,148 Common Stock
Mar 01 2023
BUY
Grant, award, or other acquisition
-
1,142 Added 1.92%
58,290 Common Stock
Feb 22 2023
BUY
Grant, award, or other acquisition
-
25,000 Added 29.85%
58,762 Common Stock
Dec 06 2022
SELL
Open market or private sale
$2,691 $10.39 p/Share
259 Reduced 0.76%
33,762 Common Stock
Dec 01 2022
SELL
Payment of exercise price or tax liability
$26,635 $10.65 p/Share
2,501 Reduced 6.85%
34,021 Common Stock
Sep 06 2022
SELL
Open market or private sale
$2,955 $11.28 p/Share
262 Reduced 0.71%
36,522 Common Stock
Sep 01 2022
SELL
Payment of exercise price or tax liability
$6,583 $11.61 p/Share
567 Reduced 1.52%
36,784 Common Stock
Jun 06 2022
SELL
Open market or private sale
$3,902 $14.95 p/Share
261 Reduced 0.69%
37,351 Common Stock
Jun 01 2022
SELL
Payment of exercise price or tax liability
$8,278 $14.6 p/Share
567 Reduced 1.49%
37,612 Common Stock
Mar 07 2022
SELL
Open market or private sale
$11,590 $25.14 p/Share
461 Reduced 1.19%
38,179 Common Stock
Mar 02 2022
SELL
Payment of exercise price or tax liability
$4,190 $26.69 p/Share
157 Reduced 0.4%
38,640 Common Stock
JA

Jason Alger

Chief Financial Officer
South Jordan, UT

Track Institutional and Insider Activities on HCAT

Follow Health Catalyst, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells HCAT shares.

Notify only if

Insider Trading

Get notified when an Health Catalyst, Inc. insider buys or sells HCAT shares.

Notify only if

News

Receive news related to Health Catalyst, Inc.

Track Activities on HCAT